• Infor Appoints Yuka Kanemitsu as President and Representative Director of Infor Japan to Accelerate Industry Cloud Growth and AI-Driven Business Transformation

    • August 6, 2026
    • Posted by: Victoria Reynolds
    • Category: Competitive research
    No Comments

    Experienced technology executive to lead Infor’s next phase of growth in Japan, helping customers modernize operations through industry-specific cloud solutions, AI, and deep industry expertise.NEW YORK and TOKYO, Aug. 5, 2026 /PRNewswire/ — Infor, the industry cloud company,…

    read more

  • Every enduring field of medicine is built on clinical architecture.

    • August 6, 2026
    • Posted by: Victoria Reynolds
    • Category: Economics
    No Comments

    DAVIS, Calif., Aug. 5, 2026 /PRNewswire/ — Over decades, women’s healthcare organized itself around three foundational pillars: reproduction, disease prevention, and longevity. Those pillars shaped research, residency training, standards of care, and ultimately the questions physicians learned to…

    read more

  • Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

    • August 6, 2026
    • Posted by: Victoria Reynolds
    • Category: Economics
    No Comments

    SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and…

    read more